PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)

$4.16 0.07 (1.7115%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) News Sources

Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO

26-02-2026

yahoo.com

Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026

10-03-2026

yahoo.com

Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

17-03-2026

yahoo.com

Myriad Genetics And 2 Other Penny Stocks To Watch Closely

06-04-2026

yahoo.com

Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer

15-04-2026

yahoo.com

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026

20-04-2026

yahoo.com

Prelude Therapeutics (PRLD) Presents Preclinical Data for KAT6A Degarader PRT13722 in Breast Cancer

01-05-2026

yahoo.com

Wall Street Analysts Think Prelude Therapeutics (PRLD) Could Surge 33.59%: Read This Before Placing a Bet

08-05-2026

yahoo.com

Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

12-05-2026

yahoo.com

Earnings Beat: Prelude Therapeutics Incorporated (NASDAQ:PRLD) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

16-05-2026

yahoo.com

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) Sentiment Trend

0 25 50 75 100 92 66 72 89 85 76 89 55 70 90 26-02-2026 10-03-2026 17-03-2026 06-04-2026 15-04-2026 20-04-2026 01-05-2026 08-05-2026 12-05-2026 16-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) FAQs

toggle

What is the current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is $4.16.


toggle

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) absolute price change since previous trading day?

The absolute price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is $0.07.


toggle

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) percentage price change since previous trading day?

The percentage price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is 1.7115%.


toggle

What is the most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is 78 out of 100.


toggle

What is the most recent average sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The most recent sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is .


SEC-8K** Filing Available For PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.